blisce/ is a B Corp certified venture capital firm founded by Alexandre Mars, investing from early to IPO across the US and Europe. Headquartered in Paris and New York, it backs founders reshaping industries with missions that matter, with a focus on consumer technology, climate, and impact-driven companies.
Founded —
Type Venture capital 3 Blisce Technology III 2026-05-18 2026-05-18 — Newervehicle formationnotice May18, deedMay13,2026. EUR100 legalcapital isnotfundcommitments;target/close unknown.
blisce/climate 2024-05-20 2024-05-20 — EUR150m fundraisingtarget announcedMay2024; no verified finalclose, amountfield omitted.
blisce/2 2023-04 2023-04 $250M USD250m finalclose reported April2023; EUR225m approximate counterpart, not separatevehicle. May23 founderinterview corroborates.
SHOW MORE
$19M 2026-06-25 Almetra blisce/ , NAP , Critical Ventures $210M 2026-02-12 Talkiatry blisce/ , Scott Kupor $— 2024-02-26 sorella blisce/ $— 2024 Almetra blisce/ $— 2023-01-26 Welcome to the Jungle blisce/ $680M 2021-09-20 Sorare Accel , Atomico , Bessemer Venture Partners , blisce/ , Felix Capital , Peter Fenton , Antoine Nussenbaum $— 2021-07-14 Wecasa blisce/ $— 2021-01-07 Too Good To Go blisce/ $53M 2020-02-12 Headspace blisce/ $— Unknown date Lokki blisce/ $— Unknown date Local Infusion blisce/ $— Unknown date Helogen blisce/ $— Unknown date Evroc blisce/ $— Unknown date Evroc blisce/ $— 2021-09-27 DICE blisce/ $— 2020-03-02 MWM Angular Ventures , blisce/ $5M 2013-10-22 Teads.tv blisce/ , Elaia $— Unknown date Welcome to the Jungle France blisce/ $— Unknown date Sorella Care blisce/ $— Unknown date DICE blisce/ $— Unknown date Candid blisce/
SHOW MORE
team@apexlogos.ai · 8 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund sizes and stages
| Vehicle / metric | Evidence and date | Interpretation |
|---|---|---|
| **blisce/2 / Fund II** | Sifted, 2023-04-14: $250m second fund closed. Founder interview in Maddyness, 2023-05-23: final close $250m. Maddyness, 2023-06-07: €225m. | Verified reported final close; USD amount and approximate EUR counterpart, not two separate funds. Latest-known sized final close found. [S4–S5] |
| **blisce/climate** | Private Equity Magazine, 2024-05-20: first-time thematic fund targeting €150m, fundraising begun earlier that year. | Target only; final size and final closing date not verified. Dedicated decarbonization strategy is distinct from Fund II. [S6] |
| **Blisce Technology III** | Formation notice published 2026-05-18, deed dated 2026-05-13; recent Treasury post lists Technology III as Tibi accredited. | Newer vehicle exists, but no verified target, first-close amount or final-close amount. The formation notice's €100 legal capital is **not fund commitments**. [S7–S8] |
| AUM | No reliable current aggregate AUM found in sources checked. | Do not infer AUM by adding historical funds or importing GP Intel's inconsistent €250m Fund II/AUM figures. |
| Historical checks | Founder interview, 2023-06-07: investments of €10–20m, with roughly six lead/co-lead transactions annually. | Historical 2023 strategy guidance, not a verified present-day minimum/maximum check range. [S5] |
**Stage strategy:** The current official homepage's structured metadata and client application state investments from early stage through IPO in the US and Europe. B Lab characterizes blisce/ as growth VC for global consumer brands and technology. A May 2023 founder interview says it generally invested starting at Series B. These are compatible with an evolving/broader present-day mandate; retain the historical date rather than flattening them into one unqualified stage range. Official/reported transactions include Almetra Series A, evroc Series A, Headspace Series C and Talkiatry Series D. A separate May 2024 report describes climate fund focus on Series A/B; no new explicit climate-stage confirmation was found. [S3–S6, S9–S13, S15]
Sources
All sources accessed **2026-10-06**. Publication dates below are explicit when available; “undated” means no verified publication date.
| Ref | Source / URL | Date; access notes |
|---|---|---|
| S1 | [Canonical Adex](https://adex.page/firms/Blisce ); local snapshot `data/research/_sources/Blisce.adex.json` | Snapshot retrieved 2026-10-06; starting evidence only. |
| S2 | [NFX Signal firm](https://signal.nfx.com/firms/blisce ) | Undated; directly read, sparse/empty team content. |
| S3 | [Official homepage](https://www.blisce.com/ ) and [B Lab certification](https://www.bcorporation.net/en-us/find-a-b-corp/company/blisce/ ) | Undated; official HTML/JS inspected, B Lab directly search-readable, certification since May 2020. |
| S4 | [Sifted Fund II closing](https://sifted.eu/articles/alexandre-mars-blisce-news ) | 2023-04-14; readable title/intro; fuller article access limited. |
| S5 | [Maddyness founder interview](https://www.maddyness.com/2023/05/23/que-font-les-fonds-blisce/ ) and [Fund II strategy](https://www.maddyness.com/2023/06/07/blisce-2-fonds-consommation/ ) | 2023-05-23 and 2023-06-07; search-readable article text. |
| S6 | [Private Equity Magazine climate launch](https://www.pemagazine.fr/odu0oq-le-first-time-fund-blisce-climate-cherche-150-me/ ) and [Zoom Invest stage report](https://www.zoominvest.fr/actualites/french-tech-alexandre-mars-lance-son-fonds-climat-9329/l9t4l09zwuqf1a3vq1lu85td ) | 2024-05-20 and 2024-05-13; search-readable. |
| S7 | [Technology III formation notice](https://annonces-legales.lefigaro.fr/annonces-legales/blisce-technology-iii-immatriculation-constitution/ ) | 2026-05-18; deed 2026-05-13. Legal notice, not fundraising announcement. |
| S8 | [French Treasury Tibi post](https://fr.linkedin.com/posts/direction-generale-du-tresor-french-treasury_linitiative-tibi-poursuit-sa-dynamique-activity-7510964349604241408-gwle ) | Exact publication date not verified; search-index accessible. Confirms listing, no fund size. |
| S9 | [Helogen company-issued release](https://www.businesswire.com/news/home/20260901393900/en/Helogen-Announces-October-Missions-to-Advance-Commercial-Manufacturing-in-Orbit-and-Establish-First-Regulatory-Pathway ) | 2026-09-01; directly read. |
| S10 | [Helogen official product site](https://www.helogen.com/ ) | Undated; directly search-readable. |
| S11 | [Almetra announcement](https://www.linkedin.com/posts/almetra-ai_today-were-excited-to-share-that-weve-activity-7475822476703223808-oGJL ), [blisce/ announcement](https://www.linkedin.com/posts/blisce_manufacturing-powers-everything-around-us-activity-7475839871488741376-WOtr ), [Vestbee funding report](https://www.vestbee.com/insights/articles/almetra-raises-19-m ) | LinkedIn dates not independently verified; Vestbee 2026-06-25 directly read. |
| S12 | [Almetra about](https://www.almetra.ai/about ) and [product site](https://www.almetra.ai/ ) | Undated; directly read. |
| S13 | [evroc official Series A announcement](https://evroc.com/news/evroc-series-a/ ) | 2025-03-20; financing completed in 2024; directly search-readable. |
| S14 | [Headspace company funding release](https://www.businesswire.com/news/home/20200212005206/en/Headspace-Announces-Fundraising-Raising-93-Million-Accelerate ) | 2020-02-12; search-readable company release. |
| S15 | [Historical founder interview](https://www.maddyness.com/2023/05/23/que-font-les-fonds-blisce/ ) | 2023-05-23; generally Series B onward. |
| S16 | [Talkiatry company Series D release](https://www.prnewswire.com/news-releases/talkiatry-raises-oversubscribed-210m-series-d-to-expand-nations-largest-full-stack-psychiatry-provider-302685678.html ) | 2026-02-12; directly read. |
| S17 | [LambdaVision mission announcement](https://www.lambdavision.com/lambdavision-advances-space-based-manufacturing-with-its-first-mission-beyond-the-iss/ ) | 2026-09-01; search-readable company release. |
| S18 | [Official public team endpoint](https://www.blisce.com/api/team ), [legal disclosure](https://www.blisce.com/legal ) | Undated; endpoint read using HTTP, legal text read in public JS; quality issues described above. |
| S19 | [Private Equity International firm profile](https://www.privateequityinternational.com/institution-profiles/blisce.html ) | Undated; search-readable team list; premium details restricted. |
| S20 | [Official 2025 impact report](https://www.blisce.com/2025-climate-and-impact-report.pdf ) | 2025 reporting period; contents unreviewed due reader size limit. |
No source here supports a firm-specific neural-interface mandate or a complete inventory of all investments. Unverified leads and conflicts are explicitly retained for later review.
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| blisce/2 | USD 250000000 | 2023-04 |
| blisce/climate | Undisclosed / unverified | 2024-05-20 |
| Blisce Technology III | Undisclosed / unverified | 2026-05-18 | SHOW MORE
team@apexlogos.ai · 9 hours ago
Match research 2026-10-06 / Blisce / sha256:c8481ccfdd07faec46a0862f4ef905a7866e1f3fe2a54433ce0da562e0f4cf10 / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
- **Talkiatry:** Company-issued release, **2026-02-12**, confirms **$210m Series D**, led by Perceptive Advisors, with blisce/ participating alongside other investors; a bank debt facility is also mentioned. It is a psychiatry care provider with AI workflow software, not a verified neurotechnology investment. The company-round amount is not Blisce's check. [S16]
- **Helogen / LambdaVision:** Helogen's customer mission manufactures protein material for LambdaVision's artificial retina. LambdaVision's own **2026-09-01** announcement supports the partnership. This is relevant retinal/vision-restoration adjacency through an investee's customer; it establishes **neither a direct blisce/ investment in LambdaVision nor Helogen ownership of the retina product**. Do not convert it into a direct neurotech participation. [S9, S17]
## Discrepancies and later Adex review notes
1. Correct location to separately supported Paris, France and New York, US. [S3]
2. Add fund objects/evidence preserving Fund II final close, climate fundraising target and Technology III unknown fundraising amounts. Do not use legal entity capital as fund size. Do not assert Fund II is latest.
3. Review duplicate **evroc** participations. Official evidence suggests a single >€50m Series A closed in 2024 and publicly announced 2025-03-20; baseline 2024-12-31 is not a verified exact closing day, and 2025-03-24 is a later news publication date. [S13]
4. Review duplicate **Almetra** records; the verified $19m Series A announcement is June 2026, while a baseline entry assigns 2024 to the same $19m blog claim. Earlier Deltia financing could exist, but that is not justification for duplicating this Series A. [S11–S12]
5. Review DICE identity: the music ticketing firm's $122m Series C should not be attributed to Dice, Inc./EarthWeb, the separate recruitment business. Likewise compare sorella/Sorella Care and the two Welcome to the Jungle names before retaining duplicate rounds. These are identity-review flags, not completed merge decisions.
6. For Helogen, company confirms participation and $7.9m cumulative funding; $7.1m seed reporting must be separately reconciled. Round totals should not populate Blisce-specific investment amounts. [S9–S10]
7. **Team evidence is conflicting/low quality.** Direct read of the official site's public `/api/team` on 2026-10-06 returns the exact Adex Prot/Lazorthes/Ryu roles, but every LinkedIn URL is only `https://linkedin.com` , biographies are generic, and the visible team page was inaccessible to the web reader. This is correlated website evidence, not robust independent biography verification. Private Equity International instead lists Alexandre Mars (Founder/CEO), Anne-Claire Colomb-Valadares (Partner/COO), Sam Giber and Charles-Henri Prevost (GPs); the official legal-page application text names Mars as CEO. Preserve the discrepancy and verify person-specific official biographies before updating roles. [S18–S19]
8. The official 2025 impact PDF was reachable by HTTP but the web reader rejected its 17.6 MB size; its contents were not reviewed. Website homepage was a client-rendered shell in the web reader; strategy and legal text were inspected directly in HTML metadata and its publicly served JavaScript. No authoritative current AUM, Fund III close size or climate final close was found.
## Sources
All sources accessed **2026-10-06**. Publication dates below are explicit when available; “undated” means no verified publication date.
| Ref | Source / URL | Date; access notes |
|---|---|---|
| S1 | [Canonical Adex](https://adex.page/firms/Blisce ); local snapshot `data/research/_sources/Blisce.adex.json` | Snapshot retrieved 2026-10-06; starting evidence only. |
| S2 | [NFX Signal firm](https://signal.nfx.com/firms/blisce ) | Undated; directly read, sparse/empty team content. |
| S3 | [Official homepage](https://www.blisce.com/ ) and [B Lab certification](https://www.bcorporation.net/en-us/find-a-b-corp/company/blisce/ ) | Undated; official HTML/JS inspected, B Lab directly search-readable, certification since May 2020. |
| S4 | [Sifted Fund II closing](https://sifted.eu/articles/alexandre-mars-blisce-news ) | 2023-04-14; readable title/intro; fuller article access limited. |
| S5 | [Maddyness founder interview](https://www.maddyness.com/2023/05/23/que-font-les-fonds-blisce/ ) and [Fund II strategy](https://www.maddyness.com/2023/06/07/blisce-2-fonds-consommation/ ) | 2023-05-23 and 2023-06-07; search-readable article text. |
| S6 | [Private Equity Magazine climate launch](https://www.pemagazine.fr/odu0oq-le-first-time-fund-blisce-climate-cherche-150-me/ ) and [Zoom Invest stage report](https://www.zoominvest.fr/actualites/french-tech-alexandre-mars-lance-son-fonds-climat-9329/l9t4l09zwuqf1a3vq1lu85td ) | 2024-05-20 and 2024-05-13; search-readable. |
| S7 | [Technology III formation notice](https://annonces-legales.lefigaro.fr/annonces-legales/blisce-technology-iii-immatriculation-constitution/ ) | 2026-05-18; deed 2026-05-13. Legal notice, not fundraising announcement. |
| S8 | [French Treasury Tibi post](https://fr.linkedin.com/posts/direction-generale-du-tresor-french-treasury_linitiative-tibi-poursuit-sa-dynamique-activity-7510964349604241408-gwle ) | Exact publication date not verified; search-index accessible. Confirms listing, no fund size. |
| S9 | [Helogen company-issued release](https://www.businesswire.com/news/home/20260901393900/en/Helogen-Announces-October-Missions-to-Advance-Commercial-Manufacturing-in-Orbit-and-Establish-First-Regulatory-Pathway ) | 2026-09-01; directly read. |
| S10 | [Helogen official product site](https://www.helogen.com/ ) | Undated; directly search-readable. |
| S11 | [Almetra announcement](https://www.linkedin.com/posts/almetra-ai_today-were-excited-to-share-that-weve-activity-7475822476703223808-oGJL ), [blisce/ announcement](https://www.linkedin.com/posts/blisce_manufacturing-powers-everything-around-us-activity-7475839871488741376-WOtr ), [Vestbee funding report](https://www.vestbee.com/insights/articles/almetra-raises-19-m ) | LinkedIn dates not independently verified; Vestbee 2026-06-25 directly read. |
| S12 | [Almetra about](https://www.almetra.ai/about ) and [product site](https://www.almetra.ai/ ) | Undated; directly read. |
| S13 | [evroc official Series A announcement](https://evroc.com/news/evroc-series-a/ ) | 2025-03-20; financing completed in 2024; directly search-readable. |
| S14 | [Headspace company funding release](https://www.businesswire.com/news/home/20200212005206/en/Headspace-Announces-Fundraising-Raising-93-Million-Accelerate ) | 2020-02-12; search-readable company release. |
| S15 | [Historical founder interview](https://www.maddyness.com/2023/05/23/que-font-les-fonds-blisce/ ) | 2023-05-23; generally Series B onward. |
| S16 | [Talkiatry company Series D release](https://www.prnewswire.com/news-releases/talkiatry-raises-oversubscribed-210m-series-d-to-expand-nations-largest-full-stack-psychiatry-provider-302685678.html ) | 2026-02-12; directly read. |
| S17 | [LambdaVision mission announcement](https://www.lambdavision.com/lambdavision-advances-space-based-manufacturing-with-its-first-mission-beyond-the-iss/ ) | 2026-09-01; search-readable company release. |
| S18 | [Official public team endpoint](https://www.blisce.com/api/team ), [legal disclosure](https://www.blisce.com/legal ) | Undated; endpoint read using HTTP, legal text read in public JS; quality issues described above. |
| S19 | [Private Equity International firm profile](https://www.privateequityinternational.com/institution-profiles/blisce.html ) | Undated; search-readable team list; premium details restricted. |
| S20 | [Official 2025 impact report](https://www.blisce.com/2025-climate-and-impact-report.pdf ) | 2025 reporting period; contents unreviewed due reader size limit. |
No source here supports a firm-specific neural-interface mandate or a complete inventory of all investments. Unverified leads and conflicts are explicitly retained for later review. SHOW MORE
team@apexlogos.ai · 9 hours ago
Match research 2026-10-06 / Blisce / sha256:c8481ccfdd07faec46a0862f4ef905a7866e1f3fe2a54433ce0da562e0f4cf10 / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# blisce/ — firm research
- Exact Adex ID: `Blisce`
- Canonical Adex URL: https://adex.page/firms/Blisce
- Research date and source access date: **2026-10-06**
- Deliverable: research only; no Adex/database mutations performed.
## Summary
blisce/ is a Paris/New York investment firm founded by Alexandre Mars, with B Corp certification and a consumer technology/growth investment history. The current official website describes investment from early stage through IPO in the US and Europe. The latest independently documented **sized final fund close** found is **blisce/2, $250 million (approximately €225 million), April 2023**. This must not be described as the firm's latest fund: a **Blisce Technology III** vehicle was formed in May 2026 and appears in a recent French Treasury Tibi accreditation announcement, but its fundraising size was not verified. A separate **blisce/climate €150 million target**, announced in May 2024, is not verified as a final close. [S3–S8]
Verified technology investments include **Helogen** (autonomous orbital biomaterial manufacturing), **Almetra** (computer vision/edge AI for manufacturing), and **evroc** (hyperscale cloud and physical AI infrastructure; a broader deep-tech interpretation). **No verified neurotech investment found in the sources checked.** Headspace and Talkiatry are mental-health investments; Helogen's work for an artificial-retina developer is an adjacent supply-chain connection, not evidence that blisce/ directly invested in that retinal technology company. [S9–S14]
## Starting evidence: Adex and NFX Signal
The exact-ID baseline is `data/research/_sources/Blisce.adex.json`, a read-only localhost MCP Search result retrieved 2026-10-06 at 19:28:56 UTC. It describes a B Corp venture firm founded by Alexandre Mars investing early to IPO, with consumer technology, climate and impact interests. `checkMin`, `checkMax` and `sweetSpot` are null; founded date is null. Sources carried in the record are https://www.blisce.com/ , https://signal.nfx.com/firms/blisce and https://goldi.ai/intelligence/vc/blisce . The evidence is dated 2026-09-14, so these are inherited claims rather than independent confirmations.
The baseline contains 21 investment participations: Talkiatry; Almetra twice; evroc twice; sorella/Sorella Care; Welcome to the Jungle/Welcome to the Jungle France; DICE under two different names, including “Dice, Inc.-EarthWeb Inc.”; Sorare; Wecasa; Too Good To Go; MWM; Headspace; Teads.tv; Candid; Helogen; Local Infusion; and Lokki. This is a baseline inventory, not a verification of every participation. Its location string `Paris, US` is inconsistent with Paris, France/New York, US. Its investor roles are Alexandre Prot and Céline Lazorthes as General Partners and Marcus Ryu as Partner. [S1]
**NFX Signal was inspected next**, directly at https://signal.nfx.com/firms/blisce . The accessible page presents the name “Blisce” and an empty “Blisce Team” heading, with no readable checks, stages, funds or investor biographies. Targeted Signal searches did not surface an attributable Alexandre Mars profile. Thus Signal supplies a matching directory URL only; no profile claims can be independently corroborated from the accessible content. This is a content/access limitation, not evidence that the firm has no team. [S2]
## Fund sizes and stages
| Vehicle / metric | Evidence and date | Interpretation |
|---|---|---|
| **blisce/2 / Fund II** | Sifted, 2023-04-14: $250m second fund closed. Founder interview in Maddyness, 2023-05-23: final close $250m. Maddyness, 2023-06-07: €225m. | Verified reported final close; USD amount and approximate EUR counterpart, not two separate funds. Latest-known sized final close found. [S4–S5] |
| **blisce/climate** | Private Equity Magazine, 2024-05-20: first-time thematic fund targeting €150m, fundraising begun earlier that year. | Target only; final size and final closing date not verified. Dedicated decarbonization strategy is distinct from Fund II. [S6] |
| **Blisce Technology III** | Formation notice published 2026-05-18, deed dated 2026-05-13; recent Treasury post lists Technology III as Tibi accredited. | Newer vehicle exists, but no verified target, first-close amount or final-close amount. The formation notice's €100 legal capital is **not fund commitments**. [S7–S8] |
| AUM | No reliable current aggregate AUM found in sources checked. | Do not infer AUM by adding historical funds or importing GP Intel's inconsistent €250m Fund II/AUM figures. |
| Historical checks | Founder interview, 2023-06-07: investments of €10–20m, with roughly six lead/co-lead transactions annually. | Historical 2023 strategy guidance, not a verified present-day minimum/maximum check range. [S5] |
**Stage strategy:** The current official homepage's structured metadata and client application state investments from early stage through IPO in the US and Europe. B Lab characterizes blisce/ as growth VC for global consumer brands and technology. A May 2023 founder interview says it generally invested starting at Series B. These are compatible with an evolving/broader present-day mandate; retain the historical date rather than flattening them into one unqualified stage range. Official/reported transactions include Almetra Series A, evroc Series A, Headspace Series C and Talkiatry Series D. A separate May 2024 report describes climate fund focus on Series A/B; no new explicit climate-stage confirmation was found. [S3–S6, S9–S13, S15]
## Previous deep-tech investments
| Company | Firm attribution and funding evidence | Technology rationale and limits |
|---|---|---|
| **Helogen** | Company-issued Business Wire release, 2026-09-01, lists Blisce among investors and reports **$7.9m raised to date**. It quotes RRE as leading a financing round but does not isolate Blisce's investment amount or clearly specify the individual round's size/date/stage. | Strong deep-tech fit: integrated spacecraft, autonomous orbital bioprocessing/manufacturing and biomaterials. Funding evidence verifies firm participation. Baseline $7.1m appears in secondary seed reporting; retain it only as a separately sourced round claim, not as company-confirmed cumulative total. October 2026 missions are planned, not completed. [S9–S10] |
| **Almetra, formerly Deltia** | Official company and firm LinkedIn posts both announce **$19m Series A led by blisce/**. Vestbee dates it **2026-06-25** and names co-investors. The baseline company blog URL failed to load. | Applied industrial deep-tech candidate: camera-based computer vision, local/edge processing, anonymization and multimodal factory intelligence. Official product/about pages confirm the physical manufacturing application. This has more technical basis than ordinary SaaS, but classification remains an analytical judgment, not proof of novel foundational AI research. [S11–S12] |
| **evroc** | Official company release **2025-03-20**: **over €50m Series A**, completed in **2024**, led by blisce/; Giant Ventures, EQT Ventures and Norrsken VC participated. | Hyperscale cloud and physical AI/data-center infrastructure. Include as infrastructure-oriented/broader deep tech, while distinguishing it from chip invention, quantum hardware or other research-intensive hardware. The announcement date and closing year differ. [S13] |
General consumer marketplaces, meditation apps, HR software, ticketing, NFT fantasy sports and music apps in the baseline are not counted as deep tech merely because they use software or AI. Additional OpenAI/AMI Labs attributions surfaced in secondary Almetra coverage, but their precise rounds/firm participation were not independently checked here and should remain follow-up leads.
## Neurotechnology and adjacent investments
**No verified neurotech investment found in the sources checked.** Searches covered blisce/ with neurotech/neurotechnology, brain and BCI terms, the starting investment inventory, the firm website, NFX and funding announcements. This is a scoped negative finding, not a claim of no such investments.
- **Headspace:** Company-issued announcement, 2020-02-12, identifies blisce/ as lead in Series C: **$53m equity plus $40m bank debt**, $93m total financing. Mindfulness/meditation software and clinical validation are mental-health/digital-health adjacency. The evidence does not establish neural sensing, stimulation, brain interfaces or an implanted neural device. Baseline “growth” can be refined to Series C, and its $93m must retain the equity/debt split. [S14] SHOW MORE
team@apexlogos.ai · 22 days ago
MATCH 
Angular Ventures
Antoine Nussenbaum
Sorare$680M · 2021-09-20
Bessemer Venture Partners
Critical Ventures
Almetra$19M · 2026-06-25
Felix Capital
Peter Fenton
Scott Kupor
Talkiatry$210M · 2026-02-12
sorella
Welcome to the Jungle
Wecasa
Too Good To Go
Headspace
Lokki
Local Infusion
Helogen
Evroc